Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Family with sequence similarity 108, member A1 pseudogene (FAM108A1 pseudogene) is a human pseudogene, meaning it is a DNA sequence similar to a functional gene but is generally non-coding and does not produce a functional protein[3][9]. Pseudogenes typically arise via gene duplication or retrotransposition and accumulate disabling mutations such as frameshifts or premature stop codons, preventing them from encoding active proteins[9]. Some pseudogenes may be transcribed as non-coding RNAs and could potentially regulate their parental gene, but for most—including this gene—no specific molecular function, disease association, or therapeutic relevance has been established[3][9]. There are no known drugs, biomarker roles, or documented biological/pathological functions for ENSG00000260159[3]. Its existence in gene catalogs primarily serves as a reference for genome annotation and potential studies of pseudogene biology.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Family with sequence similarity 108, member A1 pseudogene (FAM108A1 pseudogene).